Skip to content

Patients › Elbow

Tennis Elbow

Tennis elbow (lateral epicondylitis) — causes, symptoms, and conservative treatment options for pain relief.

Updated Sep 20261 citations
A hand-drawn illustration of a faceless person playing a tennis backhand.
Tennis elbow: irritation where the forearm tendons attach to the outer elbow. Kieran Hirpara 4.0

What you're feeling

Tennis elbow is pain on the outside of your elbow, at the bony point where your forearm muscles attach. It happens when the tendon there has become worn and irritated. It is most common between the ages of 35 and 65, and it affects about 3% of people.

The pain gets worse when you grip, lift or twist. Turning a door handle, holding a coffee cup, pouring a kettle or picking up a shopping bag can all set it off. Pressing on the outside of your elbow will usually be tender. Straightening your wrist or fingers against resistance, such as lifting with your palm facing down, often brings the pain on too.

The pain tends to flare after activity, and it can ache at night or first thing in the morning. Over weeks it can spread into daily life. Some people find work and social activities become restricted because of the pain. About 20% of people with tennis elbow have pain bad enough to limit their work and daily life.

The good news is that tennis elbow usually settles on its own. Symptoms often ease steadily over three to four months, and most cases resolve by 6 months no matter what treatment is used. About 90% of people with untreated tennis elbow find their symptoms resolve within 1 year. Even if you have had the pain for a long time, your chances of recovery over the next year stay much the same.

Because it usually settles by itself, most people do not need surgery. Surgery is generally reserved for the small percentage of people whose pain does not improve with other treatment.

What's actually happening

The sore spot is a tendon called the extensor carpi radialis brevis. It anchors your wrist and finger muscles to the bone on the outside of your elbow. Think of it as a rope anchoring a sail to a mast. Every grip, lift and twist pulls on that rope.

With repeated strain, the rope starts to wear. The body's usual repair process does not keep up, so the tendon fibres become disorganised instead of strong and lined up. This is not a swelling or a flare-up of inflammation, even though the name "epicondylitis" suggests it. It is a wearing-down problem, more like a frayed rope than a burnt one, and that is why the pain keeps returning when you use your hand.

The wearing happens exactly where the tendon meets the bone, and the load there rises when your elbow is straight and your palm is turned down. That matches the movements that hurt you: gripping, lifting with your palm facing down, twisting a handle. Your elbow's sense of its own position in space can also become less accurate, and the small muscle at the back of the elbow does not switch on as it should when you grip. This is why the problem is not just about the tendon itself. Looking after your neck, shoulder and whole arm matters too, not only the elbow.

If the pain goes on for a long time and you then injure the elbow again, a nearby ligament that steadies the joint can also be strained. That can make the elbow feel unsteady as well as painful, and it is one reason some elbows do not settle with simple treatment.

What we can do about it

Dr Kieran Hirpara, an upper-limb surgeon at Mater Private Hospital Rockhampton, starts with the least invasive options that suit your condition. Patients are generally referred to our clinic by their GP; if a physiotherapist has suggested you see us, you will still need a referral from your GP in order to be eligible for the Medicare rebate. At your first visit we take a history, examine your elbow and arrange imaging if it is needed.

Most tennis elbow settles without surgery, so we usually begin with non-operative care. You can ease the load on the tendon by changing how you grip, lift and twist at work and at home. Physiotherapy aims to settle the pain and rebuild strength in your wrist and forearm. Give it a fair go over several months. The chance of recovery stays much the same across the first year, even if the pain has been there a long while.

Pain tablets and anti-inflammatories can take the edge off, though the relief they give is small and they can cause side effects. Injections are an option we may discuss. Cortisone can settle pain in the short term. Hyaluronic acid is a lubricating fluid injected around the tendon. Platelet-rich plasma uses a sample of your own blood, processed to concentrate the healing cells, and is injected into the tendon. We will talk through what each involves and how long any effect might last before deciding together whether one suits you.

Surgery comes into the conversation when these treatments have not given you enough improvement and the pain is still limiting your work or daily life. The operation cleans out the worn, frayed part of the tendon where it attaches to the bone on the outside of your elbow. We consider it a shared decision, made together once you understand what it involves and what it can and cannot do for you.

What to expect

The outlook for tennis elbow is mostly a good one, and you have already read the numbers: most elbows settle within a year, whatever treatment is used. The pain tends to fade steadily rather than disappear overnight. Over weeks and months you should notice flare-ups becoming shorter and lighter, and everyday grips like holding a kettle or turning a handle becoming easier. Having had the pain a long time does not make your chances of recovery any worse.

If your elbow does not settle with the simpler treatments, surgery is still a reasonable path. Some procedures for long-standing tennis elbow report success rates of 75% to 80%.

It is worth knowing that surgery is not a guaranteed fix. A small number of people, about 1.5%, need a further operation later on. Having three or more injections before surgery makes that more likely. As with any operation, there are general risks such as infection or stiffness, and some procedures can leave the elbow slightly stiffer than before.

So the honest picture is this: your elbow will most likely settle on its own or with physiotherapy and sensible changes to how you use your arm. If it does not, surgery helps most people who reach that point, but not everyone.

When to see someone

Most tennis elbow settles by itself, so time is usually the main treatment. See your GP if the pain on the outside of your elbow has lasted more than 6 weeks, or if it keeps you from working or sleeping. Ask for a specialist review if simple treatment and physiotherapy over several months have not helped, or if your elbow feels unsteady as well as painful, since a strained ligament can sometimes be part of the problem. Tell your GP how many injections you have had, because three or more steroid injections before any operation makes further surgery later more likely. If you notice warmth, redness or fever with the pain, see your GP promptly rather than waiting for it to settle.

In more depth

Advanced reading: the deeper science (optional)

This section goes further than you need for your own treatment decisions. Tennis elbow is worth the extra reading because it is one of the conditions where the treatment that feels most effective in the first month is the one that does worst by the end of the year.

The condition mostly cures itself, slowly

Left alone, tennis elbow settles. In the trial discussed below, the group randomised to simply wait and see, no injection, no physiotherapy, was reassessed at 52 weeks, and 56 of 62 (90%) reported themselves either much improved or completely recovered [1].

That figure is the yardstick every treatment has to be measured against. An intervention is only worth having if it beats getting better on your own, and getting better on your own is what usually happens.

The corticosteroid paradox

A landmark randomised trial compared corticosteroid injection, physiotherapy, and simply waiting, following people for a full year [1].

At six weeks the injection looked excellent. Success was reported by 51 of 65 (78%) of the injection group against 16 of 60 (27%) of those waiting, a number needed to treat of 2 [1].

Then it reversed. Of those early successes, 47 of 65 (72%) subsequently regressed. By 52 weeks the injection group was significantly worse than the physiotherapy group on every outcome, and worse than the people who did nothing on two of the three primary measures [1].

The authors' own explanation is worth repeating: the injection relieves pain so quickly that people resume loading a tendon that has not actually healed. The trial's conclusion was that corticosteroid "should be used with caution" in tennis elbow, a striking thing to say about the treatment most people expect to be offered.

This is why an injection here is a considered decision about short-term function, not a default, and why it is not a substitute for the loading programme.

So what is worth doing

Physiotherapy beat waiting at six weeks on every measure, and by 52 weeks the two were indistinguishable because nearly everyone in both groups had recovered [1]. Its value is therefore in getting you through the painful months faster, not in changing the destination. Notably, the physiotherapy group also sought less additional treatment along the way [1]. Given that, the sensible plan is load management and a progressive tendon programme, accepting that the timeline is measured in months.

Surgery is reserved for the small minority still disabled after a genuine and prolonged trial of non-operative care. The reason that threshold is set high is precisely the natural history above: operate early and you are competing against a condition that was, in nine cases out of ten, going to resolve anyway.

Cultured tendon-cell injection

You may be offered, or may read about, autologous tenocyte implantation (ATI, sold in Australia as OrthoATI), an injection of your own laboratory-grown tendon cells. It is safe, it is biologically sensible, and the results reported in stubborn tennis elbow have lasted more than four years. It is also supported, in the whole world literature, by five studies containing 50 patients between them, not one of which had a comparison group. Set that against the natural history above and the placebo-surgery result, and the reason for caution becomes obvious. There is a full account of what is and is not known, with references, on the autologous tenocyte implantation page.


References for the advanced reading
  1. Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006;333(7575):939.
Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • The term 'Tennis Elbow' is considered inaccurate by some authors [1].
  • The diagnosis of tennis elbow is often made too quickly [1].
  • Rapid diagnosis may contribute to high rates of recalcitrant complaints due to insufficient consideration of differential diagnoses [1].
  • Approximately 90% of people with untreated tennis elbow achieve symptom resolution at 1 year based on placebo or no-treatment control arms of randomized trials [3].
  • Pooled data from randomized controlled trials indicate a lack of intermediate- to long-term clinical benefit after nonsurgical treatment of lateral epicondylitis compared with observation only or placebo [4].
  • No single universally accepted protocol has emerged for the treatment of epicondylitis despite numerous available options [7].
  • Most patients with lateral epicondylitis resolve spontaneously or with standard conservative management [12].
  • Refractory cases of lateral epicondylitis may benefit from interventional therapies or surgical approaches [12].
  • Current research evidence suggests that surgery for tennis elbow is no more effective than nonsurgical treatment, based on evidence with significant methodological limitations [31].
  • There was insufficient evidence to support or refute the effectiveness of surgery for lateral elbow pain due to a small number of studies, large heterogeneity in interventions, small sample sizes, and poor reporting of outcomes [11].
  • Denervation of the elbow for management of tennis elbow is a simple safe procedure [16].

Anatomy & Pathophysiology

Anatomy

  • The pathology of lateral epicondylitis is primarily localized to the origin of the extensor carpi radialis brevis (ECRB) [51].
  • The ECRB and extensor digitorum communis (EDC) have tendinous origins and lie deep to the extensor carpi radialis longus (ECRL), which has a muscular origin [51].
  • The common extensors lie superficial to the lateral collateral ligament complex proximally and to the supinator distally [51].
  • The ECRB tendon lies superficial to the joint capsule, making it accessible arthroscopically [51].
  • The posterior interosseous nerve enters the supinator distal to the radial head [51].
  • Compression of the posterior interosseous nerve at the radial tunnel can coexist with lateral epicondylitis [51].
  • The pathologic process mainly involves the origin of the extensor carpi radialis brevis but can involve the tendons of the extensor carpi radialis longus and the extensor digitorum communis [52].
  • The anatomic basis of the injury to the extensor carpi radialis brevis origin involves hypovascular zones, eccentric tendon stresses, and a microscopic degenerative response [25].

Pathophysiology

  • Lateral epicondylitis is initiated as a microtear, most often within the origin of the extensor carpi radialis brevis [52].
  • The current consensus is that lateral epicondylitis is a degenerative process rather than an inflammatory one [25].
  • Histologic studies of lateral epicondylitis show angiofibroblastic hyperplasia [51, 52].
  • Histologic findings include neovascularization, infiltration by mucopolysaccharide, a disordered collagen scaffold, bone formation, and angiofibroblastic proliferation [51].
  • Inflammation is not usually seen in lateral epicondylitis but is likely present in the early stages [51].
  • The lesion occurs in a vascular watershed area that is relatively avascular, limiting healing potential [51].
  • Eccentric contractions of the extensor carpi radialis brevis muscle during backhand tennis swings are the likely cause of repetitive microtrauma that causes tears in the tendon and lateral epicondylitis [35].
  • The presence of hypoechogenicity and bone changes on ultrasound indicates the presence of a stressed common extensor origin-lateral epicondyle complex in elbows with lateral epicondylalgia [5].
  • Repetitive exposure to bending and straightening the elbow is a significant risk factor for lateral epicondylitis [84].
  • There is a strong association between combined physical exertion and elbow movements and lateral epicondylitis [8].
  • Biomechanical exposure involving the wrist and/or elbow at work is associated with the incidence of lateral epicondylitis [57].

Classification

  • The term "Tennis Elbow" is considered inaccurate, and the diagnosis is often made too quickly, which may explain high rates of recalcitrant complaints due to insufficient consideration of differential diagnoses [1].
  • A considerable terminological heterogeneity exists in the description of lateral elbow pain, associated with a lack of clear and recognized diagnostic criteria [30].
  • Approximately 46.5% of patients presenting with lateral-sided elbow pain are diagnosed with a condition other than lateral epicondylitis [14].
  • The findings of an epidemiologic study are consistent with the hypothesis that tennis elbow is a degenerative disease, the onset of which is hastened by overuse of the arm and elbow [13].
  • Pathologic tissue studies have noted a failed reparative process rather than active inflammation in lateral epicondylitis [25].
  • The presence of hypoechogenicity and bone changes on musculoskeletal ultrasound indicates the presence of a stressed common extensor origin-lateral epicondyle complex in elbows with lateral epicondylalgia [5].
  • Accurate diagnosis of medial epicondylitis requires distinguishing it from other elbow conditions, and treatment is guided by the specific pathologic stage of the tendon [10].
  • The arthroscopic identification of three types of Baker lesions helps the surgeon confirm the presence of pathology commonly seen intra-articularly in patients with lateral epicondylitis [68].
  • Failed surgical treatment of lateral epicondylitis is multifactorial, and distinguishing the cause is critical for appropriate management [15].

Clinical Presentation

  • The term 'Tennis Elbow' is considered inaccurate, and the diagnosis is often made too quickly, potentially explaining high rates of recalcitrant complaints due to insufficient consideration of differential diagnoses [1].
  • Lateral epicondylitis is a common, generally self-limiting tendinosis affecting patients aged 35 to 55 years [26].
  • The findings are consistent with the hypothesis that tennis elbow is a degenerative disease, the onset of which is hastened by overuse of the arm and elbow [13].
  • Almost half of the patients (46.5%) presenting with lateral sided elbow pain were diagnosed with a condition other than lateral epicondylitis [14].
  • A considerable terminological heterogeneity exists in the description of lateral elbow pain, associated with the lack of clear and recognised diagnostic criteria [30].
  • The diagnosis of lateral epicondylitis based on Japanese Orthopaedic Association guidelines requires pain in the elbow joint within 2 weeks, pain in the lateral epicondyle region on resisted extension of the wrist with the elbow extended, and tenderness in the lateral epicondyle [46].
  • Tenderness for the diagnosis of lateral epicondylitis is considered positive if observed in the lateral epicondyle or adjacent tissue up to 4 cm distal to the epicondyle and elicited by any degree of palpation [46].
  • Physical examination of the elbow should focus on functional anatomy and includes inspection, palpation, range of motion, strength, stability, and special tests [54].
  • The history is the most valuable tool to guide the clinical examination, with location, quality, context, duration, and severity of elbow pain being important for understanding pathology [54].
  • Determining the symptom trajectory (whether pain is getting better, worse, or remaining constant) is helpful when considering intervention [54].
  • Characteristic elements of the history for lateral elbow tendinopathy include pain lifting things from a bag with a pronated hand, turning doorknobs, taking milk from the fridge, shaking hands, taking a laptop out of a bag, and bumping the lateral elbow [54].
  • Physical examination maneuvers to elicit lateral elbow tendinopathy include direct palpation of the ECRB origin, the tennis elbow shear test, pain with resisted wrist or long finger extension, and the laptop test [54].
  • Imaging studies to evaluate lateral elbow tendinopathy include MRI if the lateral ulnar collateral ligament is suspected as part of the pathology and ultrasonography [54].

Investigations

Clinical Diagnosis and Differential Diagnosis

  • The physical exam is directed by history and the location of the patient's pain in the anterior, posterior, medial, or lateral aspect of the elbow [49].

Imaging: Ultrasound

  • Ultrasonographic imaging of the elbow includes imaging techniques and the normal appearance of anatomic structures [44].

Imaging: Magnetic Resonance Imaging (MRI)

  • The routine use of MRI for the diagnosis of lateral epicondylitis is low, although its use is associated with downstream effects [69].
  • Increased MRI signal in the extensor carpi radialis brevis (ECRB) origin is common in both symptomatic and asymptomatic elbows [70].
  • MRI can be used to evaluate ligaments and tendons of the elbow, but it is rarely indicated [45].
  • The reliability and validity of magnetic resonance imaging in the assessment of chronic lateral epicondylitis has been evaluated [47].
  • Magnetic resonance evaluation of the elbow includes the review of ligament complexes [44].
  • A review of the MR appearance of osseous and soft-tissue anatomy of the elbow, as well as commonly encountered pathology including overuse injury, has been performed [44].

Imaging: Radiographs and CT

  • Plain radiographs remain the hallmark and the best screening test for the evaluation of the elbow [49].
  • Standard AP, lateral, and oblique radiographs are obtained for elbow evaluation, with serial radiography used as follow-up when heterotopic ossification is present [45].
  • CT is helpful when assessing for malunion architecture and the location and pattern of osteophytes and/or loose bodies [45].
  • Three-dimensional CT is used to check for heterotopic ossification [45].
  • CT is not necessary when elbow stiffness is entirely soft-tissue related [45].

Neurological Assessment

  • Electromyography/nerve conduction velocity studies should be performed if any question about neurologic dysfunction exists [45].
  • An assessment for ulnar nerve subluxation should be performed, as subluxation of the nerve is a relative contraindication for an arthroscopic procedure secondary to possible iatrogenic nerve injury [45].

Treatment

Non-Operative Management

  • Approximately 90% of people with untreated tennis elbow achieve symptom resolution at 1 year [3].
  • Lateral epicondylitis is usually self-limited, resolving over a 12- to 18-month period without treatment [33].
  • The probable best recommendation for treatment is oral analgesics for symptom relief, activity modification, and a plan of “waiting things out” for up to 18 months [42].
  • Corticosteroid injection has little, if any, benefit over placebo and usually does not change the natural history of the disease [42].
  • Recent data suggest that poorer results are seen in the intermediate and long term following corticosteroid injections relative to placebo [42].
  • Patients who undergo corticosteroid injection may actually be worse at the end of a year [42].
  • The significant short-term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates [22].
  • Peri-articular hyaluronic acid treatment for tennis elbow was significantly better than control in improving pain at rest and after maximal grip testing [61].
  • Nonsurgical treatment is the mainstay of management for lateral epicondylitis, involving options such as rest, physical therapy, and injections [62].
  • Nonoperative treatment for epicondylitis has a success rate of up to 90% [66].
  • A high-repetition, low-resistance home exercise program may be useful for lateral epicondylitis [42].
  • There is wide variability of treatments offered when physiotherapy fails patients with tennis elbow [28].
  • Further investigations are needed on tendinopathies in other areas of the upper limb, including epicondylar tendinopathy [18].

Operative Management

  • There was insufficient evidence to support or refute the effectiveness of surgery for lateral elbow pain due to small number of studies, heterogeneity, small sample sizes, and poor reporting [11].
  • Greater than 90% of people with lateral epicondylitis are successfully treated nonoperatively [21].
  • Most surgical patients for lateral epicondylitis are in their fifth decade of life, have had symptoms for an average of 19 months, and have had failure of nonoperative treatment including an average of 3.1 corticosteroid injections [21].
  • The majority of patients undergoing surgery for lateral epicondylitis have surgery on their dominant elbow, with an average incidence of dominant arm involvement of 74% [21].
  • Outcomes between open and arthroscopic surgical procedures for lateral epicondylitis are comparable [42].
  • Arthroscopic treatment of lateral epicondylitis is accompanied by an increased risk of neurovascular injury and instability compared with open release of the elbow [42].
  • Good to excellent results have been achieved in 83% to 96% of patients using variations in technique for medial epicondylitis [42].
  • Poorer outcomes are reported in patients with ulnar nerve symptoms undergoing medial epicondylitis surgery [42].
  • Surgical intervention for refractory medial epicondylitis often has a high success rate with patients generally demonstrating an improvement in patient-reported outcomes and an encouraging number returning to work with limited complications [17].
  • The median time of minimum conservative management before surgery for lateral epicondylitis was six months [64].
  • Surgical intervention is reserved for patients with continued symptoms after 6 months or more of treatment [43].
  • There is no good algorithm for the type of surgical treatment that is most effective for lateral epicondylitis [21].
  • No single universally accepted protocol has emerged for the treatment of epicondylitis [7].

Complications

  • Corticosteroid injections have a short-term beneficial effect on lateral epicondylitis, but a negative effect in the intermediate term [32].
  • The significant short-term benefits of corticosteroid injection are reversed after six weeks, with high recurrence rates [22].
  • Heterotopic ossification has been reported as a complication following elbow arthroscopy for lateral epicondylitis [39].
  • Three or more preoperative injections is the most significant risk factor for revision surgery after operative treatment of lateral epicondylitis [71].
  • Short-term complication rates appear comparable between open and arthroscopic treatment of lateral epicondylitis [73].

Recovery

  • Lateral epicondylitis often resolves spontaneously, warranting considerable circumspection before embarking on treatment [19].
  • The prognosis for medial epicondylitis in occupational settings was good with a 3-year recovery rate at 81% [20].
  • Poor prognosis at 1 year of follow-up for lateral epicondylitis was related to manual work and high baseline pain [77].
  • No relation was found between the type of medical treatment given or chosen and prognosis for lateral epicondylitis at 1 year [77].
  • The annual incidence of lateral epicondylitis per 10,000 patients and the proportion of cases treated surgically remained constant from 2007 to 2014 [38].

Key Evidence

  • [Letter] The authors agree that the term 'Tennis Elbow' is inaccurate and that the diagnosis is often made too quickly, potentially explaining high rates of recalcitrant complaints due to insufficient consideration of differential diagnoses. [1] (10.1177/1758573218816086)
  • [L1] Based on the placebo or no-treatment control arms of randomized trials, about 90% of people with untreated tennis elbow achieve symptom resolution at 1 year. [3] (10.1097/corr.0000000000002058)
  • [L1] Pooled data from RCTs indicate a lack of intermediate- to long-term clinical benefit after nonsurgical treatment of lateral epicondylitis compared with observation only or placebo. [4] (10.1007/s11999-014-4022-y)
  • [L4] The presence of hypoechogenicity and bone changes indicates presence of a stressed common extensor origin-lateral epicondyle complex in elbows with lateral epicondylalgia. [5] (10.1186/1471-2342-14-10)
  • [L5] This article is a review of recently published information on elbow tendinopathy and tendon ruptures intended to assist clinicians in diagnosis and management, noting that while numerous treatment options exist for epicondylitis, no single universally accepted protocol has emerged. [7] (10.1016/j.jhsa.2009.01.022)
  • [L4] This study emphasizes the strength of the associations between combined physical exertion and elbow movements and lateral epicondylitis. [8] (10.1002/ajim.22140)
  • [L5] Accurate diagnosis requires distinguishing it from other elbow conditions, and treatment is guided by the specific pathologic stage of the tendon. [10] (10.1016/j.csm.2004.04.011)
  • [L1] Due to a small number of studies, large heterogeneity in interventions across trials, small sample sizes and poor reporting of outcomes, there was insufficient evidence to support or refute the effectiveness of surgery for lateral elbow pain. [11] (10.1002/14651858.cd003525.pub2)
  • [L4] Most patients with lateral epicondylitis resolve spontaneously or with standard conservative management, but refractory cases may benefit from interventional therapies or surgical approaches. [12] (10.5397/cise.2019.22.4.227)
  • [L4] The findings are consistent with the hypothesis that tennis elbow is a degenerative disease, the onset of which is hastened by overuse of the arm and elbow. [13] (10.1177/036354657900700405)
  • [L3] Almost half of the patients (46.5%) were diagnosed with a diagnosis other than lateral epicondylitis. [14] (10.1016/j.jseint.2024.08.047)
  • [L5] Failed surgical treatment of lateral epicondylitis is multifactorial, and distinguishing the cause is critical for appropriate management. [15] (10.1016/j.xrrt.2023.07.006)
  • [L2] Denervation of the elbow for management of tennis elbow is a simple safe procedure. [16] (10.5435/jaaosglobal-d-24-00352)
  • [L4] Surgical intervention for refractory medial epicondylitis often has a high success rate with patients generally demonstrating an improvement in patient-reported outcomes and an encouraging number returning to work with limited complications. [17] (10.1177/03635465221095565)
  • [L2] Further investigations are needed, not only focused on shoulder impingement or epicondylar tendinopathy, but on tendinopathies in other areas of the upper limb. [18] (10.1016/j.jsams.2015.06.007)
  • [L4] Overall, the available data suggest that lateral epicondylitis often resolves spontaneously, warranting considerable circumspection before embarking on treatment. [19] (10.1016/j.otsr.2019.09.004)
  • [L2] The prognosis for medial epicondylitis in this population was good with a 3-year recovery rate at 81%. [20] (10.1097/01.jom.0000085888.37273.d9)
  • [L4] [21] (10.1097/blo.0b013e3181483dc4)
  • [L1] The significant short term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates, implying that this treatment should be used with caution in the management of tennis elbow. [22] (10.1136/bmj.38961.584653.ae)
  • [L4] [25] (10.1016/j.jhsa.2007.07.019)
  • [L5] Lateral epicondylitis is a common, generally self-limiting tendinosis affecting patients aged 35 to 55 years. [26] (10.1302/0301-620x.95b9.29285)
  • [L4] There is wide variability of treatments offered when physiotherapy fails patients with tennis elbow. [28] (10.1177/1758573217738199)
  • [L1] In this SR, a considerable terminological heterogeneity emerged in the description of LEP, associated with the lack of clear and recognised diagnostic criteria in evaluating and treating patients with lateral elbow pain. [30] (10.3390/healthcare10061095)
  • [L1] Current research evidence suggests that surgery for tennis elbow is no more effective than nonsurgical treatment based on evidence with significant methodological limitations. [31] (10.1177/1758573217745041)
  • [L1] Corticosteroid injections have a shortterm beneficial effect on lateral epicondylitis, but a negative effect in the intermediate term. [32] (10.1136/bmjopen-2013-003564)
  • [L2] Lateral epicondylitis is a condition that is usually self-limited, resolving over a 12- to 18-month period without treatment. [33] (10.1007/s11552-014-9642-x)
  • [L5] [35] (10.1016/j.csm.2004.06.004)
  • [L4] The annual incidence of lateral epicondylitis per 10,000 patients and the proportion of cases treated surgically remained constant from 2007 to 2014. [38] (10.1007/s11420-017-9559-3)
  • [L4] To our knowledge, we present the first case of HO development after elbow arthroscopy for lateral epicondylitis. [39] (10.1177/1558944716668844)
  • [L3] [46] (10.1016/j.jseint.2024.01.008)
  • [L2] The results of this meta-analysis strongly support the hypothesis of an association between biomechanical exposure involving wrist and/or elbow at work and incidence of lateral epicondylitis. [57] (10.1002/acr.22874)
  • [L1] Peri-articular HA treatment for tennis elbow was significantly better than control in improving pain at rest and after maximal grip testing. [61] (10.1186/1758-2555-2-4)
  • [L5] Nonsurgical treatment is the mainstay of management for lateral epicondylitis, involving options such as rest, physical therapy, and injections. [62] (10.5435/00124635-200801000-00004)
  • [L4] [64] (10.1016/j.xrrt.2024.08.008)
  • [Paper] The article reviews the pathology, clinical presentation, and treatment options for lateral and medial epicondylitis in athletes, noting that nonoperative treatment has a success rate of up to 90% and that surgical options are reserved for recalcitrant cases. [66] (10.1016/j.csm.2010.06.009)
  • [L4] The arthroscopic identification of the 3 types of Baker lesions helps the surgeon to confirm the presence of pathology commonly seen intra-articularly in patients with lateral epicondylitis. [68] (10.1016/j.eats.2024.103142)
  • [L3] Although there is variation in the use of MRI for lateral epicondylitis and its use is associated with downstream effects, the routine use of MRI for the diagnosis of lateral epicondylitis is low. [69] (10.1016/j.jhsa.2023.03.025)
  • [L4] Increased MRI signal in the ECRB origin is common in symptomatic and in asymptomatic elbows. [70] (10.1016/j.jse.2016.01.033)
  • [L4] [71] (10.1016/j.jse.2016.10.022)
  • [L3] Surgical management of lateral epicondylitis varies depending on surgeons' fellowship training, and short-term complication rates appear comparable between open and arthroscopic treatment. [73] (10.1016/j.arthro.2017.04.078)
  • [L2] Poor prognosis at 1yr of follow-up for lateral epicondylitis was related to manual work and high baseline pain, whilst no relation was found between the type of medical treatment given/chosen and prognosis. [77] (10.1093/rheumatology/keg360)
  • [L4] Repetitive exposure to bending/straightening the elbow was a significant risk factor for medial and lateral epicondylitis. [84] (10.1093/rheumatology/ker228)

References

[1] In response to the letter to the editor by Dr. Dimitrios Stasinopoulos. Shoulder & Elbow. 2019. DOI: 10.1177/1758573218816086

[3] Persistent Tennis Elbow Symptoms Have Little Prognostic Value: A Systematic Review and Meta-analysis. Clinical Orthopaedics & Related Research. 2021. DOI: 10.1097/corr.0000000000002058

[4] Does Nonsurgical Treatment Improve Longitudinal Outcomes of Lateral Epicondylitis Over No Treatment? A Meta-analysis. Clinical Orthopaedics & Related Research. 2015. DOI: 10.1007/s11999-014-4022-y

[5] The diagnostic validity of musculoskeletal ultrasound in lateral epicondylalgia: a systematic review. BMC Medical Imaging. 2014. DOI: 10.1186/1471-2342-14-10

[7] Elbow Tendinopathy and Tendon Ruptures: Epicondylitis, Biceps and Triceps Ruptures. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.01.022

[8] Work‐related risk factors for lateral epicondylitis and other cause of elbow pain in the working population. American Journal of Industrial Medicine. 2012. DOI: 10.1002/ajim.22140

[10] Diagnosis and treatment of medial epicondylitis of the elbow. Clinics in Sports Medicine. 2004. DOI: 10.1016/j.csm.2004.04.011

[11] Surgery for lateral elbow pain. Cochrane Database of Systematic Reviews. 2011. DOI: 10.1002/14651858.cd003525.pub2

[12] Current Trends for Treating Lateral Epicondylitis. Clinics in Shoulder and Elbow. 2019. DOI: 10.5397/cise.2019.22.4.227

[13] An epidemiologic study of tennis elbow. The American Journal of Sports Medicine. 1979. DOI: 10.1177/036354657900700405

[14] Clinical Diagnosis Of Lateral Sided Elbow Pain: A Prediction Model To Recognise A Diagnosis Other Than A Tennis Elbow. JSES International. 2024. DOI: 10.1016/j.jseint.2024.08.047

[15] Failed surgical treatment for lateral epicondylitis: literature review and treatment considerations for successful outcomes. JSES Reviews, Reports, and Techniques. 2024. DOI: 10.1016/j.xrrt.2023.07.006

[16] A Comparative Study Between Denervation and Extensor Release for Management of Resistant Tennis Elbow. JAAOS: Global Research and Reviews. 2026. DOI: 10.5435/jaaosglobal-d-24-00352

[17] Surgical Techniques and Clinical Outcomes for Medial Epicondylitis: A Systematic Review. The American Journal of Sports Medicine. 2022. DOI: 10.1177/03635465221095565

[18] Effectiveness of the eccentric exercise therapy in physically active adults with symptomatic shoulder impingement or lateral epicondylar tendinopathy: A systematic review. Journal of Science and Medicine in Sport. 2016. DOI: 10.1016/j.jsams.2015.06.007

[19] Management of lateral epicondylitis. Orthopaedics & Traumatology: Surgery & Research. 2019. DOI: 10.1016/j.otsr.2019.09.004

[20] Medial Epicondylitis in Occupational Settings: Prevalence, Incidence and Associated Risk Factors. Journal of Occupational and Environmental Medicine. 2003. DOI: 10.1097/01.jom.0000085888.37273.d9

[21] Surgical Treatment of Lateral Epicondylitis. Clinical Orthopaedics & Related Research. 2007. DOI: 10.1097/blo.0b013e3181483dc4

[22] Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006. DOI: 10.1136/bmj.38961.584653.ae

[25] Lateral Epicondylitis: Review and Current Concepts. The Journal of Hand Surgery. 2007. DOI: 10.1016/j.jhsa.2007.07.019

[26] Lateral epicondylitis. The Bone & Joint Journal. 2013. DOI: 10.1302/0301-620x.95b9.29285

[28] Management of tennis elbow: a survey of UK clinical practice. Shoulder & Elbow. 2017. DOI: 10.1177/1758573217738199

[30] Treatment, Diagnostic Criteria and Variability of Terminology for Lateral Elbow Pain: Findings from an Overview of Systematic Reviews. Healthcare. 2022. DOI: 10.3390/healthcare10061095

[31] Surgery for tennis elbow: a systematic review. Shoulder & Elbow. 2017. DOI: 10.1177/1758573217745041

[32] Treating lateral epicondylitis with corticosteroid injections or non-electrotherapeutical physiotherapy: a systematic review. BMJ Open. 2013. DOI: 10.1136/bmjopen-2013-003564

[33] Non-Surgical Treatment of Lateral Epicondylitis: A Aystematic Review of Randomized Controlled Trials. HAND. 2014. DOI: 10.1007/s11552-014-9642-x

[35] Lateral epicondylitis. Clinics in Sports Medicine. 2004. DOI: 10.1016/j.csm.2004.06.004

[38] Epidemiology and Disease Burden of Lateral Epicondylitis in the USA: Analysis of 85, 318 Patients. HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery. 2018. DOI: 10.1007/s11420-017-9559-3

[39] Heterotopic Ossification After the Arthroscopic Treatment of Lateral Epicondylitis. HAND. 2017. DOI: 10.1177/1558944716668844

[42] Green S Operative Hand Surgery. Surgical Treatment > Expected Outcomes.

[43] Orthopaedic Knowledge Update Sports Medicine 6. Chronic/Overuse Elbow Disorders > Summary.

[44] Orthopaedic Knowledge Update Sports Medicine 6. Magnetic Resonance Imaging of the Elbow > Annotated References.

[45] Aaos Comprehensive Orthopaedic Review 3. Elbow Stiffness* > IV. Evaluation.

[46] Prevalence and factors associated with lateral epicondylitis among hospital healthcare workers. JSES International. 2024. DOI: 10.1016/j.jseint.2024.01.008

[47] Campbell S Operative Orthopaedics 4 Volume Set. ELBOW, WRIST, AND HAND.

[49] Orthopaedic Knowledge Update 13 Ebook Without Multimedia. Anatomy, Biomechanics, Physical Examination, and Imaging of the Elbow > Summary and Conclusions.

[51] Aaos Comprehensive Orthopaedic Review 3. Lateral and Medial Epicondylitis > I. Lateral Epicondylitis.

[52] Campbell S Operative Orthopaedics 4 Volume Set. POSTERIOR SURGICAL APPROACH FOR QUADRILATERAL SPACE SYNDROME > ELBOW INJURIES > ELBOW TENOPATHIES.

[54] Orthopaedic Knowledge Update 13 Ebook Without Multimedia. Anatomy, Biomechanics, Physical Examination, and Imaging of the Elbow > Biomechanics > Clinical Examination.

[57] Lateral Epicondylitis and Physical Exposure at Work? A Review of Prospective Studies and Meta‐Analysis. Arthritis Care & Research. 2016. DOI: 10.1002/acr.22874

[61] Management of Tennis Elbow with sodium hyaluronate periarticular injections. BMC Sports Science, Medicine and Rehabilitation. 2010. DOI: 10.1186/1758-2555-2-4

[62] Management of Lateral Epicondylitis: Current Concepts. Journal of the American Academy of Orthopaedic Surgeons. 2008. DOI: 10.5435/00124635-200801000-00004

[64] Surgical management of lateral epicondylitis: a scoping review of published literature. JSES Reviews, Reports, and Techniques. 2025. DOI: 10.1016/j.xrrt.2024.08.008

[66] Epicondylitis in the Athlete’s Elbow. Clinics in Sports Medicine. 2010. DOI: 10.1016/j.csm.2010.06.009

[68] Recognition and Differentiation of Baker Lesions in Lateral Epicondylitis During Arthroscopic Debridement. Arthroscopy Techniques. 2024. DOI: 10.1016/j.eats.2024.103142

[69] The Use and Downstream Associations of Magnetic Resonance Imaging for Lateral Epicondylitis. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2023.03.025

[70] Incidental magnetic resonance imaging signal changes in the extensor carpi radialis brevis origin are more common with age. Journal of Shoulder and Elbow Surgery. 2016. DOI: 10.1016/j.jse.2016.01.033

[71] Three or more preoperative injections is the most significant risk factor for revision surgery after operative treatment of lateral epicondylitis: an analysis of 3863 patients. Journal of Shoulder and Elbow Surgery. 2017. DOI: 10.1016/j.jse.2016.10.022

[73] Trends in Surgical Treatment of Lateral Epicondylitis Among Recently Trained Orthopaedic Surgeons. Arthroscopy. 2017. DOI: 10.1016/j.arthro.2017.04.078

[77] Prognostic factors in lateral epicondylitis: a randomized trial with one-year follow-up in 266 new cases treated with minimal occupational intervention or the usual approach in general practice. Rheumatology. 2003. DOI: 10.1093/rheumatology/keg360

[84] Occupation and epicondylitis: a population-based study. Rheumatology. 2011. DOI: 10.1093/rheumatology/ker228

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.